IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 25 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01528-07v1
76/5/2149    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitaker, S. M.
Right arrow Articles by McMahon-Pratt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitaker, S. M.
Right arrow Articles by McMahon-Pratt, D.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01528-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through TLR4

Shanta M. Whitaker, Maria Colmenares, Karen Goldsmith Pestana, and Diane McMahon-Pratt*

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain

* To whom correspondence should be addressed. Email: diane.mcmahon-pratt{at}yale.edu.


   Abstract

The P8 proteoglycolipid complex (P8 PGLC) is a glyconjugate expressed by L. mexicana complex parasites. We previously have shown that vaccination with the P8 PGLC provides protection against cutaneous leishmaniasis in susceptible BALB/c mice. However, the biological importance of this complex remains unknown. Herein we show that P8 PGLC localizes to the surface of L. pifanoi amastigotes and upon exposure to macrophages, P8 PGLC binds and induces inflammatory cytokine and chemokine mRNAs such as TNF{alpha} and RANTES early after stimulation. Our studies indicate that cytokine and chemokine induction is dependent upon TLR4. Interestingly, key inflammatory cytokines and chemokines (such as IL-6,MIP-1{beta}, IFN{beta}) that can be induced through TLR4 activation, were not induced or only slightly upregulated by P8 PGLC. Activation by P8 PGLC does not occur in the presence of TLR4 alone and requires both CD14 and MD-2 for signaling; this requirement may be responsible for the limited TLR4 response. This is the first characterization of a TLR4 ligand for Leishmania. In vitro experiments indicate that L. pifanoi amastigotes induce lower levels of cytokines in macrophages in the absence of TLR4; however, notably higher IL-10/IFN{gamma} ratios were found for TLR4 deficient mice than BALB/c mice. Further, increased levels of parasites persist in BALB/c mice deficient in TLR4. Taken together, these results suggest that TLR4 recognition of Leishmania pifanoi amastigotes is important for the control of infection and that this is mediated, in part, through the P8 PGLC.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.